期刊文献+

鞘氨醇激酶2与蛋白激酶D参与调控丁酸钠诱导的人肝癌细胞凋亡 被引量:5

Protein kinase D and sphingosine kinase 2 are involved in sodium butyrate-induced apoptosis in human liver cancer HepG2 cells
下载PDF
导出
摘要 目的探讨蛋白激酶D(PKD)与鞘氨醇激酶2(SphK2)参与调控丁酸钠诱导的人肝癌HepG2细胞凋亡的分子机制。方法采用流式细胞仪检测不同浓度丁酸钠作用48 h后人肝癌HepG2细胞的凋亡率,以及干扰或过表达PKD或SphK2对丁酸钠诱导人肝癌HepG2细胞凋亡率的影响;并且在分别干扰PKD或SphK2后以免疫印迹法检测其对丁酸钠诱导另一蛋白激活(磷酸化)的影响。结果丁酸钠能明显诱导HepG2细胞凋亡(P<0.01),且具有浓度依赖性;而在PKD或SphK2被干扰后,丁酸钠诱导细胞凋亡率比未干扰细胞明显增高(P<0.01),而过表达PKD或SphK2的细胞在丁酸钠作用下其凋亡率比空质粒对照组细胞明显下降(P<0.01),并且干扰PKD可阻断丁酸钠诱导的SphK2激活(P<0.01),而干扰SphK2则对PKD的激活无影响(P<0.01)。结论 PKD和SphK2均可负性调控丁酸钠诱导的HepG2细胞凋亡。 Objective To explore the roles of protein kinase D (PKD) and sphingosine kinase 2 (SphK2) in sodium butyrate-induced apoptosis of human liver cancer HepG2 cells. Method Using flow cytometry, the percentage of apoptotic HepG2 cells was examined after treatment with sodium butyrate of different concentrations. The effects of down-regulation and over-expression of SphK2 or PKD on sodium butyrate-induced apoptosis were analyzed. With Western blotting, the changes in the activated (phosphorylated) forms of Results SphK2 or PKD induced by sodium butyrate with or without interference of the other enzyme were detected Sodium butyrate induced apoptosis of HepG2 ceils significantly (P 〈 0. 01 ) in a concentration- dependent manner. After the down-regulation of PKD or SphK2, the sodium butyrate-induced apoptosis was obviously potentiated, as compared to the non-interfered control cells (P 〈0. 01 ). On the contrary, the apoptosis of the cells with PKD or SphK2 overexpressed was significantly prohibited, in comparison with the vehicle plasmid-transfected cells (P 〈0. 01 ). Moreover, the interference of SphK2 did not affect activation of PKD by sodium butyrate (P 〈 0. 01 ), while PKD down-regulation resulted in the absence of SphK2 activation ( P 〈 0. 01 ). Conclusion Both SphK2 and PKD negatively regulate apoptosis of HepG2 cells induced by sodium butyrate.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第3期262-266,共5页 Journal of Third Military Medical University
基金 广东省自然科学基金(S2012010008922) 广东医学院博士启动项目(B2012032)~~
关键词 丁酸钠 HEPG2细胞 蛋白激酶D 鞘氨醇激酶2 凋亡 sodium butyrate HepG2 cell line protein kinase D sphingosine kinase 2 apoptosis
  • 相关文献

参考文献15

  • 1Wlodkowic D,Telford W,Skommer J,et al.Apoptosis and beyond:cytometry in studies of programmed cell death[J].Methods Cell Biol,2011,103:55-98.
  • 2Favaloro B,Allocati N,Graziano V,et al.Role of apoptosis in disease[J].Aging(Albany NY),2012,4(5):330-349.
  • 3Steliou K,Boosalis M S,Perrine SP,et al.Butyrate histone deacety-lase inhibitors[J].Biores Open Access,2012,1(4):192-198.
  • 4Joachimiak R,Kaznica A,Drewa T.Influence of sodium butyrate onhepatocellular carcinoma(hepG2)and glioblastoma(C6)cell lines invitro[J].Acta Pol Pharm,2007,64(6):561-563.
  • 5Xiao M,Liu Y,Zou F.Sensitization of human colon cancer cells to so-dium butyrate-induced apoptosis by modulation of sphingosine kinase 2and protein kinase D[J].Exp Cell Res,2012,318(1):43-52.
  • 6Hait N C,Bellamy A,Milstien S,et al.Sphingosine kinase type 2activation by ERK-mediated phosphorylation[J].J Biol Chem,2007,282(16):12058-12065.
  • 7Yamamoto H,Fujimoto J,Okamoto E,et al.Suppression of growth ofhepatocellular carcinoma by sodium butyrate in vitro and in vivo[J].Int J Cancer,1998,76(6):897-902.
  • 8Sun B,Liu R,Xiao Z D,et al.c-MET protects breast cancer cellsfrom apoptosis induced by sodium butyrate[J].PLoS One,2012,7?1):e30143.
  • 9Rawluszko A A,Slawek S,Gollogly A,et al.Effect of butyrate on aro-matase cytochrome P450 levels in HT29,DLD-1 and LoVo colon canc-er cells[J].Biomed Pharmacother,2012,66(2):77-82.
  • 10Paskova L,Smesny-Trtkova K,Fialova B,et al.Different effect ofsodium butyrate on cancer and normal prostate cells[J].Toxicol InVitro,2013,27(5):1489-1495.

同被引文献44

  • 1易军,鲁茁壮,段海峰,盖鲁粤,王立生.肝细胞生长因子通过鞘氨醇激酶途径诱导内皮细胞迁移作用的研究[J].中国应用生理学杂志,2006,22(2):230-234. 被引量:2
  • 2刘成霞,张尚忠,张孝卫,黄丽华,李铁军,张静,王兵.丁酸钠诱导HT-29结肠癌细胞凋亡及其对p53靶基因的调控[J].中国肿瘤生物治疗杂志,2006,13(3):185-190. 被引量:2
  • 3姜大磊,高艳景,付金栋,宋健华,许建民.SPK/S1P信号途径对人肝癌细胞VEGF表达的作用[J].山东大学学报(医学版),2007,45(3):250-252. 被引量:2
  • 4何勇勇.鞘氨醇激酶1对肝癌门静脉癌栓患者预后影响的研究[D].苏州大学,2012.
  • 5Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5) :277-300.
  • 6Tandon M, Johnson J, Li Z, et al. New pyrazolopyrimidine in- hibitors of protein kinase d as potent anticancer agents for prostate cancer cells[ J/OL]. PLoS One, 2013 [ 2015-09-12]. http:// www. ncbi. nlm. nih. gov/pmc/articles/pmid/24086585.
  • 7Wei N, Chu E, Wu SY, et al. The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer ceils [ J ]. Oncotarget, 2015, 6 (7) :4745-4756.
  • 8Navarro MN, Goebel J, Hukelmann JL, et al. Quantitative phospho- pmteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks[J]. Mol Cell Proteomics, 2014, 13(12) :3544-3557.
  • 9Tandon M, Salamoun JM, Carder EJ, et al. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest [ J/OL ]. PLoS One, 2015 [ 2015-10-01 ]. http:// www.ncbi.nlm, nih.gov/pmc/articles/pmid/25747583.
  • 10Huck B, Duss S, Hausser A, et al. Elevated protein kinase D3 ( PKD3 ) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation [J]. J Biol Chem, 2014, 289(6) : 3138-3147.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部